venBio Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 58
  • Portfolio
  • 23
  • Exits
  • 31
Exits

venBio General Information

Description

Founded in 2009, venBio is a venture capital firm headquartered in San Francisco, California. The firm seeks to invest in the life science, healthcare, therapeutics and life science sectors.

Contact Information

Website
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 1700 Owens Street
  • Suite 595
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000

venBio Investments (58)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
IO Biotech 13-Jan-2021 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 3
000000 00000000000 01-Dec-2020 00000 00000 0000 Drug Discovery Startup
00000000 30-Nov-2020 00000 00000 00000 Drug Discovery Startup 00000 0000000 00
000000000 00000000 18-Nov-2020 00000 00000 0000 Drug Discovery Startup 0000000 000000 00.0
000000000 18-Nov-2020 00000 00000 0000 Drug Discovery Generating Revenue 0000000 000000 00.0
000000000 00000000 09-Nov-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 0000000 000000 00.0
00000 00000000 13-Oct-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1
00000000 14-Sep-2020 00000 00000 000.00 Drug Discovery Clinical Trials - General 0000000 000000 00.0
RayzeBio 05-Aug-2020 Early Stage VC 0000 Drug Discovery Startup 00000 0000000 00
PMV Pharma 03-Aug-2020 Later Stage VC 0000 Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 58 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

venBio Exits (31)

Company Name Exit Date Exit Type Exit Size
ALX Oncology 10-Dec-2020 Public Investment 2nd Offering 00000
00000 00000000 19-Nov-2020 000 00000
000000 16-Oct-2020 000 00000
000 000000 25-Sep-2020 000 00000
000000000 16-Sep-2020 000 0000
0000000 0000000000 19-Aug-2020 000 00000
000000000 00000000 07-Aug-2020 000 0000
000 00000000 17-Jul-2020 000 00000
Akero Therapeutics 09-Jul-2020 Public Investment 2nd Offering 00000
Avadel Pharmaceuticals 29-Apr-2020 Public Investment 2nd Offering 00000
You’re viewing 10 of 31 exits. Get the full list »

venBio Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

venBio Team (12)

Name Title Deals Funds Boards Office
Robert Adelman MD Managing Partner & Co-Founder 00 0 0 San Francisco, CA
Aaron Royston MD Managing Partner 00 0 0 San Francisco, CA
Corey Goodman Ph.D Managing Partner 00 0 0 San Francisco, CA
Richard Gaster Ph.D Partner 0 0 0 San Francisco, CA
Yvonne Yamanaka Ph.D Principal 0 0 0 San Francisco, CA
You’re viewing 5 of 12 team members. Get the full list »

venBio Co-Investors (123)

Name With Exits Lead Partner Series Industry
Vivo Capital 11 0 0 Series chart Industry bar
Cormorant Asset Management 0 0 0 Series chart Industry bar
Novo Holdings 0 00 Series chart Industry bar
HBM Healthcare Investments 0 0 Series chart Industry bar
RA Capital Management 0 0 0 Series chart Industry bar
You’re viewing 5 of 123 co-investors. Get the full list »